TELA Bio (NASDAQ:TELA) reported third-quarter financial results on Tuesday. The transcript from the company's third-quarter earnings call has been provided below.This transcript is brought to you by Benzinga APIs. Forread more...
TELA Bio (NASDAQ:TELA) reported third-quarter financial results on Tuesday. The transcript from the company's third-quarter earnings call has been provided below.This transcript is brought to you by Benzinga APIs. Forread more...
TELA Bio (TELA) delivered earnings and revenue surprises of +31.58% and +0.31%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?
Arcus Biosciences (RCUS) delivered earnings and revenue surprises of -8.70% and -24.24%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?
Oculis Holding AG (OCS) delivered earnings and revenue surprises of +24.49% and -96.93%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?
(RTTNews) - Medical technology company TELA Bio, Inc. (TELA) announced Monday that its Liora Monofilament Scaffold product was granted 510(k) clearance by the U.S. Food and Drug Administration...
TELA Bio (TELA) delivered earnings and revenue surprises of -17.65% and -3.55%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
Puma Biotech (PBYI) delivered earnings and revenue surprises of +90.00% and +6.27%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
(RTTNews) - On Tuesday, TELA Bio, Inc. (TELA), a commercial-stage medical technology company for soft tissue reconstruction, announced the appointment of Heather Getz as Chief Executive Officer and Director, effective today...